Structure–activity relationships and cellular mechanism of action of small molecules that enhance the delivery of oligonucleotides

Abstract The pharmacological effects of antisense and siRNA oligonucleotides are hindered by the tendency of these molecules to become entrapped in endomembrane compartments thus failing to reach their targets in the cytosol or nucleus. We have previously used high throughput screening to identify small molecules that enhance the escape of oligonucleotides from intracellular membrane compartments and have termed such molecules OECs (oligonucleotide enhancing compounds). Here, we report on the structure–activity relationships of a family of OECs that are analogs of a hit that emerged from our original screen. These studies demonstrate key roles for the lipophilic aromatic groups, the tertiary nitrogen, and the carbamate moiety of the parent compound. We have also investigated the intracellular site of action of the OECs and have shown that activity is due to the release of oligonucleotides from intermediate endosomal compartments rather than from early endosomes or from highly acidic downstream compartments. At high concentrations of OECs toxicity occurs in a manner that is independent of caspases or of lysosomal cathepsins but instead involves increased plasma membrane permeability. Thus, in addition to describing specific characteristics of this family of OECs, the current study provides insights into basic mechanisms of oligonucleotide trafficking and their implications for oligonucleotide delivery.

[1]  Hong Cao,et al.  Guanabenz (Wytensin™) selectively enhances uptake and efficacy of hydrophobically modified siRNAs , 2015, Nucleic acids research.

[2]  Judy Lieberman,et al.  Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown , 2015, Nature Biotechnology.

[3]  V. Venditto,et al.  Designer lipids for drug delivery: from heads to tails. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[4]  D. Corey,et al.  Silencing disease genes in the laboratory and the clinic , 2012, The Journal of pathology.

[5]  Sarah Seifert,et al.  Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape , 2013, Nature Biotechnology.

[6]  Peter Vandenabeele,et al.  Determination of apoptotic and necrotic cell death in vitro and in vivo. , 2013, Methods.

[7]  A. Krainer,et al.  RNA therapeutics: beyond RNA interference and antisense oligonucleotides , 2012, Nature Reviews Drug Discovery.

[8]  M. Jäättelä,et al.  Lysosomal cell death at a glance , 2013, Journal of Cell Science.

[9]  J. Gruenberg,et al.  Lipid sorting and multivesicular endosome biogenesis. , 2013, Cold Spring Harbor perspectives in biology.

[10]  S. Crooke,et al.  Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides , 2017, Nucleic acids research.

[11]  E. Wickstrom DNA and RNA derivatives to optimize distribution and delivery. , 2015, Advanced drug delivery reviews.

[12]  H. Cai,et al.  Coats, tethers, Rabs, and SNAREs work together to mediate the intracellular destination of a transport vesicle. , 2007, Developmental cell.

[13]  Shimeng Liu,et al.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine. , 2014, Nanomedicine.

[14]  G. Kroemer,et al.  Lysosomal membrane permeabilization in cell death , 2008, Oncogene.

[15]  R. L. Juliano,et al.  High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides , 2015, Nucleic acids research.

[16]  Shi Xu,et al.  Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. , 2013, Advanced drug delivery reviews.

[17]  R. Juliano,et al.  Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides. , 2012, Bioconjugate chemistry.

[18]  G. Salvesen,et al.  Cysteine Cathepsins Trigger Caspase-dependent Cell Death through Cleavage of Bid and Antiapoptotic Bcl-2 Homologues* , 2008, Journal of Biological Chemistry.

[19]  D. Green,et al.  Die another way – non-apoptotic mechanisms of cell death , 2014, Journal of Cell Science.

[20]  S. Dowdy Overcoming cellular barriers for RNA therapeutics , 2017, Nature Biotechnology.

[21]  Herbert Waldmann,et al.  Identification of siRNA delivery enhancers by a chemical library screen , 2015, Nucleic acids research.

[22]  M. Abrahamson,et al.  Inhibition of lipopolysaccharide‐induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors , 2017, Journal of leukocyte biology.

[23]  Madelyn Light,et al.  Identification of the endosomal sorting complex required for transport-I (ESCRT-I) as an important modulator of anti-miR uptake by cancer cells , 2014, Nucleic acids research.

[24]  G. Cheng,et al.  Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses , 2013, Proceedings of the National Academy of Sciences.

[25]  C. Ungermann,et al.  Principles of membrane tethering and fusion in endosome and lysosome biogenesis. , 2014, Current opinion in cell biology.

[26]  Stanley T Crooke,et al.  Cellular uptake and trafficking of antisense oligonucleotides , 2017, Nature Biotechnology.

[27]  S. Emr,et al.  A Nobel Prize for membrane traffic: Vesicles find their journey’s end , 2013, The Journal of cell biology.

[28]  C. Stein,et al.  FDA-Approved Oligonucleotide Therapies in 2017. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[29]  B. Shutinoski,et al.  Cathepsins Limit Macrophage Necroptosis through Cleavage of Rip1 Kinase , 2014, The Journal of Immunology.

[30]  S. Kornbluth,et al.  Cellular mechanisms controlling caspase activation and function. , 2013, Cold Spring Harbor perspectives in biology.

[31]  G. Robertson,et al.  Effect of lysosomotropic molecules on cellular homeostasis , 2017, Pharmacological research.

[32]  B. Sullenger,et al.  From the RNA world to the clinic , 2016, Science.

[33]  Gert Storm,et al.  Endosomal escape pathways for delivery of biologicals. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[34]  H. Soifer,et al.  Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents , 2009, Nucleic acids research.

[35]  M. Manoharan,et al.  Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes , 2011, Nucleic acids research.

[36]  R. Juliano,et al.  The delivery of therapeutic oligonucleotides , 2016, Nucleic acids research.

[37]  P. Boisguérin,et al.  Delivery of therapeutic oligonucleotides with cell penetrating peptides☆ , 2015, Advanced Drug Delivery Reviews.

[38]  John J Rossi,et al.  RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise? , 2016, Annual review of pharmacology and toxicology.

[39]  Ari Helenius,et al.  Endosome maturation , 2011, The EMBO journal.

[40]  Thomas Farkas,et al.  Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress. , 2005, Cancer research.

[41]  Maria Markaki,et al.  Crosstalk between apoptosis, necrosis and autophagy. , 2013, Biochimica et biophysica acta.

[42]  J. Cintrat,et al.  The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides , 2013, Nucleic acids research.

[43]  W. Janzen,et al.  A Novel Family of Small Molecules that Enhance the Intracellular Delivery and Pharmacological Effectiveness of Antisense and Splice Switching Oligonucleotides. , 2017, ACS chemical biology.

[44]  J. Gruenberg,et al.  Endosome maturation, transport and functions. , 2014, Seminars in cell & developmental biology.

[45]  B. Chazotte Labeling lysosomes in live cells with LysoTracker. , 2011, Cold Spring Harbor protocols.

[46]  B. Brodská,et al.  Dose‐dependent effects of the caspase inhibitor Q‐VD‐OPh on different apoptosis‐related processes , 2011, Journal of cellular biochemistry.

[47]  V. Haucke,et al.  At the Crossroads of Chemistry and Cell Biology: Inhibiting Membrane Traffic by Small Molecules , 2012, Traffic.

[48]  P. Angus,et al.  Hepatitis C virus-induced hepatocyte cell death and protection by inhibition of apoptosis. , 2014, The Journal of general virology.

[49]  Xiaoyuan Chen,et al.  Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis , 2008, Nucleic acids research.

[50]  Wenqing Gao,et al.  Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death. , 2017, Trends in biochemical sciences.

[51]  George A. Calin,et al.  RNAi Therapies: Drugging the Undruggable , 2014, Science Translational Medicine.

[52]  S. Pfeffer Rab GTPase regulation of membrane identity. , 2013, Current opinion in cell biology.

[53]  B. Baker,et al.  Pharmacology of Antisense Drugs. , 2017, Annual review of pharmacology and toxicology.

[54]  Samir El Andaloussi,et al.  Delivery is key: lessons learnt from developing splice‐switching antisense therapies , 2017, EMBO molecular medicine.